A novel approach to calculating the kinetically derived maximum dose.

Area of Science:

• Toxicology
• Pharmacokinetics
• Biochemistry

Background:

• The kinetically derived maximal dose (KMD) is crucial for determining safe chemical exposure levels.
• Current methods often rely on area under the curve (AUC), which has limitations.
• A more robust toxicological framework for KMD determination is needed.

Purpose of the Study:

• To develop a novel, mathematically rigorous method for calculating the KMD.
• To integrate toxicokinetic data with Michaelis-Menten kinetics for improved accuracy.
• To establish a toxicologically relevant upper range for chemical safety assessment.

Main Methods:

• Utilized Bayesian methods to convert toxicokinetic data into a system-wide Michaelis-Menten curve.
• Employed the "kneedle" algorithm to identify the "knee" or "elbow" of the curve, indicating diminishing returns.
• Defined KMD as the region where kinetic rate approaches the Michaelis-Menten asymptote (Vmax).

Main Results:

• Successfully integrated toxicokinetic principles within the Michaelis-Menten framework.
• Established a new methodology for KMD calculation based on biochemical and toxicokinetic principles.
• Identified KMD as a region rather than a single inflection point, reflecting inherent uncertainty.

Conclusions:

• The revised KMD methodology provides a more theoretically sound and toxicologically relevant upper limit for chemical safety.
• This approach leverages established concepts like enzyme saturation for better prediction of chemical behavior.
• The new method offers a more nuanced understanding of chemical safety limits by defining KMD as a region.